郭廣昌:復星(00656.HK)未來將注重輕資產營運
由上海市浙江商會主辦的第七屆世界浙商上海論壇暨商會2023年會在上海中心大廈舉行。復星國際(00656.HK)董事長郭廣昌在演講中表示,復星最重要的聚焦是兩個板塊,一個是生物醫藥、大健康,第二個就是文旅板塊,尤其是冰雪旅遊。
郭廣昌稱,認為目前部分企業受累高負債及重資產,目前重資產的收入是不可能承擔很高資金成本的,這是不可持續。不過,他強調即使有壓力,也要堅持活下去才有希望,並注重輕資產營運的能力,抓輕資產營運的機遇。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.